Advanced search
Publication Cover
Gynecological Endocrinology Volume 29, 2013 - Issue 10
Submit an article Journal homepage
408
Views
9
CrossRef citations to date
0
Altmetric
Contraception

Toward a new concept of “natural balance” in oral estroprogestin contraception

Nathalie Chabbert-BuffetDepartment of Obstetrics and Gynecology, APHP Tenon Hospital, University Pierre and Marie Curie Paris 06 ParisFrance
,
Jan GerrisDepartment of Reproductive Medicine, Ghent University Hospital GhentBelgium
,
Christian Jamin169, boulevard Haussmann ParisFrance
,
Stefano LelloGynecology Unit, Madonna delle Grazie Clinic Velletri, RomeItaly
,
Inaki LeteDepartment of Obstetrics and Gynaecology, Hospital Santiago Apóstol Vitoria-GasteizSpain
,
Paloma LoboService of Obstetrics and Gynecology, Hospital Universitario Infanta Sofía San Sebastián de los Reyes, MadridSpain
,
Rossella E. NappiResearch Center for Reproductive Medicine, and Unit of Gynecologic Endocrinology and Menopause, IRCCS Policlinico San Matteo, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia PaviaItalyCorrespondence[email protected]
&
Axelle PintiauxDepartment of Obstetrics and Gynecology, Citadelle Hospital, Liège University LiègeBelgium
 show all
Pages 891-896 | Received 23 Jun 2013, Accepted 10 Jul 2013, Published online: 09 Aug 2013

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Maurizio Guida, Luciano Quercitelli, Pasquale De Franciscis, Cinzia Ferrara, Marco Marietta, Mattia Iaccheri, Fabio Facchinetti, Filomena Capasso & Giovanni Grandi. (2023) A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns. The European Journal of Contraception & Reproductive Health Care 28:6, pages 308-312.
Read now
Anita L Nelson. (2015) An update on new orally administered contraceptives for women. Expert Opinion on Pharmacotherapy 16:18, pages 2759-2772.
Read now
Iñaki Lete, Nathalie Chabbert-Buffet, Christian Jamin, Stefano Lello, Paloma Lobo, Rossella E. Nappi & Axelle Pintiaux. (2015) Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review. The European Journal of Contraception & Reproductive Health Care 20:5, pages 329-343.
Read now
Edith Weisberg. (2014) Developments in contraception. Expert Opinion on Pharmacotherapy 15:2, pages 203-210.
Read now

Articles from other publishers (5)

I. Lete. (2022) Evolución del estrógeno en la anticoncepción hormonal combinada: del etinilestradiol al estetrol pasando por el estradiol. Clínica e Investigación en Ginecología y Obstetricia 49:3, pages 100755.
Crossref
Rossella Nappi, Lara Tiranini, Simona Sacco, Eleonora De Matteis, Roberto De Icco & Cristina Tassorelli. (2022) Role of Estrogens in Menstrual Migraine. Cells 11:8, pages 1355.
Crossref
Simona Sacco, Gabriele S. Merki-Feld, Karen Lehrmann Ægidius, Johannes Bitzer, Marianne Canonico, Tobias Kurth, Christian Lampl, Øjvind Lidegaard, E. Anne MacGregor, Antoinette MaassenVanDenBrink, Dimos-Dimitrios Mitsikostas, Rossella Elena Nappi, George Ntaios, Per Morten Sandset & Paolo Martelletti. (2017) Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). The Journal of Headache and Pain 18:1.
Crossref
Luiz R. Falleiros-Júnior, Ana P. S. Perez, Sebastião R. Taboga, Fernanda C. A. dos Santos & Patrícia S. L. Vilamaior. (2016) Neonatal exposure to ethinylestradiol increases ventral prostate growth and promotes epithelial hyperplasia and inflammation in adult male gerbils. International Journal of Experimental Pathology 97:5, pages 380-388.
Crossref
Marta Martín Millán & Santos Castañeda. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 615 634 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.